UK markets closed

Xilio Therapeutics, Inc. (XLO)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
1.0800+0.0300 (+2.86%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
120,385
198,053
19,238
48,845
Total cash
120,385
198,053
19,238
48,845
Other current assets
4,111
4,464
1,352
2,259
Total current assets
124,496
202,517
20,590
51,104
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
17,258
16,309
15,036
10,203
Accumulated depreciation
-4,418
-2,712
-1,360
-330
Net property, plant and equipment
12,840
13,597
13,676
9,873
Other long-term assets
1,829
1,946
2,051
1,745
Total non-current assets
14,669
15,543
15,727
11,618
Total assets
139,165
218,060
36,317
62,722
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
6,667
-
2,333
-
Accounts payable
3,125
3,144
5,444
2,518
Accrued liabilities
10,327
8,751
13,732
2,689
Other current liabilities
82
82
82
-
Total current liabilities
21,119
12,778
22,155
5,207
Non-current liabilities
Long-term debt
3,165
9,628
7,412
9,610
Other long-term liabilities
45
118
1,127
374
Total non-current liabilities
12,399
19,853
97,449
87,038
Total liabilities
33,518
32,631
119,604
92,245
Stockholders' equity
Common stock
3
3
0
0
Retained earnings
-249,108
-160,886
-85,086
-29,867
Total stockholders' equity
105,647
185,429
-83,287
-29,523
Total liabilities and stockholders' equity
139,165
218,060
36,317
62,722